Pregabalin Synthir is a prescription-only neuromodulating agent indicated for the management of neuropathic pain and selected neurological disorders. It supports symptom control by reducing abnormal neuronal signaling associated with pain transmission and neurological hyperexcitability.

Developed and presented in line with internationally recognized pharmaceutical quality requirements, the product reflects a commitment to consistent performance, safety, and regulatory compliance.